Skip to main content

Table 3 Primary and secondary outcomes in the ITT population (N = 480)

From: Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (The IMMENSE study) – a randomized controlled trial

Primary outcome after 12 months

Intervention

Control

 

(n=244)

(n=236)

Crude

Adjusteda

 

n,  median (IQR)

n, median (IQR)

Incidence rate ratio (95 % CI)

Emergency medical visits

497

1 (0-3)

499

1 (0-3)

0.95 (0.75-1.20)

1.02 (0.82-1.27)

   ED-visits

277

1 (0-2)

276

1 (0-2)

0.95 (0.72-1.26)

1.02 (0.78-1.33)

   Readmissions

220

1 (0-1)

223

0 (0-1.75)

0.96 (0.73-1.25)

1.01 (0.78-1.30)

Secondary outcomes

Days to first event

median (%)

median (%)

Hazard rate (95 % CI)

    Emergency medical visit

137

(71.3)

110

(70.3)

0.93 (0.75-1.15)

0.96 (0.78-1.19)

    Readmission

310

(50.8)

356

(47.5)

1.05 (0.81-1.35)

1.10 (0.85-1.42)

 

n (%)

n (%)

Odds ratio (95 % CI)

Readmissions within 30 days

26

(10.7)

33

(14.0)

0.73 (0.42-1.27)

0.82 (0.46-1.44)

All-cause mortality within 12 months

48

(19.7)

46

(19.5)

1.01 (0.64-1.59)

1.06 (0.67-1.69)

  1. IQR Interquartile Range
  2. a) Adjusted for the number of emergency medical visits during 365 days prior to the index hospital stay